Morgan Joseph Downgrades Celgene (CELG) to Hold; Deceleration in Revenues Imminent
Tweet Send to a Friend
Morgan Joseph downgraded Celgene (NASDAQ: CELG) from Buy to Hold.
Morgan analyst says, "Following the company's 4Q10 earnings and conference ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan analyst says, "Following the company's 4Q10 earnings and conference ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
